Nathan Singh, MD, and David Porter, MD: How I Manage CAR T-Cell Therapy – Clinical Oncology News
|
Nathan Singh, MD, and David Porter, MD: How I Manage CAR T-Cell Therapy
Clinical Oncology News The human immune system has powerful potential to fight cancer, mediated in large part by T lymphocytes. Autologous T cells may not be effective to protect against or treat a patient's cancer for many reasons. In particular, they may not recognize the … |
